某肿瘤医院癌痛治疗药物使用情况动态分析
|
摘要
目的分析某肿瘤医院癌痛治疗药品的使用情况,为临床合理用药提供参考。方法通过医院HIS系统查询2018年1—3月肿瘤相关病房癌痛治疗药物使用信息,以药品名称、规格、药品消耗数量(支或片)、同期相关病房癌痛治疗药物消耗总量等为基础进行分析;同时对各个肿瘤相关科室随机抽查住院癌痛患者10例,对阶梯用药情况进行分析。结果癌痛病房所使用的止痛药以口服(包括外用贴剂)药为主(占总消耗量的86.64%),与世界卫生组织(WHO)推荐的口服给药为缓解癌痛的最佳给药途径相符。3个阶梯消耗量构成比分别为5.58%、31.67%、62.75%,其中治疗重度疼痛的第三阶梯药物占很大比例。结论该院癌痛患者止痛治疗基本合理、用药安全、有效,但对于癌痛治疗中辅助用药的使用不够重视,仍需要进一步加强监管。
Objective To analyze the use of cancer pain drugs in a hospital so as to provide the reference for clinical rational drug use.Methods The HIS system of the hospital was used to inquire about the information of drug use in cancerrelated wards from January, 2018 to March, 2018. The drug names, specifications, drug consumption amount(branch or tablet), total drug consumption in the cancer-related wards during the same period were tabulated and analyzed. Ten hospitalized patients with cancer pain were randomly sampled, and the ladder drug use was analyzed.Results The main analgesics used in the cancer pain wards were oral(including topical patches), accounting for 86.64% of the total consumption, which was consistent with the oral administration recommended by World Health Organization(WHO) as the best way to relieve cancer pain. The percentages of the consumption of the three ladders were 5.58%, 31.67% and 62.75% respectively.The third ladder drugs for severe pain accounted for a large proportion.Conclusion The analgesic therapy for cancer pain patients is basically rational, safe and effective. However, there are still individual problems, for example, the enough attention of the use of adjuvant drugs in cancer pain treatment is not paid to, and therefore, the supervision still should be strengthened.
Objective To analyze the use of cancer pain drugs in a hospital so as to provide the reference for clinical rational drug use.Methods The HIS system of the hospital was used to inquire about the information of drug use in cancerrelated wards from January, 2018 to March, 2018. The drug names, specifications, drug consumption amount(branch or tablet), total drug consumption in the cancer-related wards during the same period were tabulated and analyzed. Ten hospitalized patients with cancer pain were randomly sampled, and the ladder drug use was analyzed.Results The main analgesics used in the cancer pain wards were oral(including topical patches), accounting for 86.64% of the total consumption, which was consistent with the oral administration recommended by World Health Organization(WHO) as the best way to relieve cancer pain. The percentages of the consumption of the three ladders were 5.58%, 31.67% and 62.75% respectively.The third ladder drugs for severe pain accounted for a large proportion.Conclusion The analgesic therapy for cancer pain patients is basically rational, safe and effective. However, there are still individual problems, for example, the enough attention of the use of adjuvant drugs in cancer pain treatment is not paid to, and therefore, the supervision still should be strengthened.
引文
[1]傅玉新,曾文谊,林颖,等.我院癌症患者三阶梯止痛药物使用情况分析[J].中国药业,2014,23(14):80-82.
[2]郑淑娇,谢丽平.2011-2012年我院门诊癌痛患者阿片类药物的使用分析[J].临床合理用药杂志,2014,7(5):61-62.
[3]林华,刘琦瑛,玉环县.2011年癌痛患者麻醉药品使用情况分析[J].中国医药导报,2014,11(6):96-99.
[4]张仪娜,郑玲利.癌症止痛药物利用与处方分析[J].中国煤炭工业医学杂志,2015,18(2):335-338.
[5]温永柯.我院癌痛患者三阶梯止痛药物使用调查分析[J].北方药学,2015,12(7):151-152.
[6]官毅红.晚期癌症患者麻醉药品用药情况分析[J].海峡药学,2015,27(11):226-227.
[7]程凯,蔡虹.2009年至2011年我院癌痛治疗药品利用分析[J].中国药业,2013,22(8):82-84.
[8]王晓梅,张倩,王松芝.2010~2011年我院病区麻醉药品应用分析[J].中国现代药物应用,2012,6(3):84-85.
[9]訾梅,李玉欢.我院癌痛示范病房2012年麻醉性镇痛药用药分析[J].首都医药,2013,20(10):55-57.
[10]李雪妍.我院门诊麻醉性镇痛药品使用情况分析[J].当代医学,2011,17(10):139-141.
[11]梁晓华.癌痛镇痛药物的规范应用[J].上海医药,2011,32(12):585-589.
[12]贺尔.癌性疼痛患者住院期间麻醉药品处方分析[J].中国药物滥用防治杂志,2012,18(2):99-101.
[13]樊艳丽,尹珊珊,朱珠.芬太尼透皮贴剂的安全性及其合理使用[J].药物不良反应杂志,2017,19(12):281.
[14]黄峰,艾素梅,王伟.2009-2011年住院患者麻醉性镇痛药应用分析与评价[J].实用医技杂志,2012,19(6):579-582.
[15]肖毅军,司红霞,王迎红,等.硫酸吗啡控释片剂量滴定控制癌性疼痛的临床研究[J].中国肿瘤临床,2000,38(2):42-45.
[16]李玉齐,秦鑫添,温宗秋.盐酸羟考酮控释片治疗中、重度癌痛的临床观察[J].中外医疗,2010,29(2):17-18,20.
[17]陈理明,李晓洁,谢晓原,等.镇痛泵持续静脉泵注吗啡控制难治性癌痛的临床观察[J].肿瘤防治研究,2016,39(8):1014-1016.
[18]石春生.2009-2011年我院麻醉药品应用分析[J].中国医院用药评价与分析,2017,12(7):594-596.
[2]郑淑娇,谢丽平.2011-2012年我院门诊癌痛患者阿片类药物的使用分析[J].临床合理用药杂志,2014,7(5):61-62.
[3]林华,刘琦瑛,玉环县.2011年癌痛患者麻醉药品使用情况分析[J].中国医药导报,2014,11(6):96-99.
[4]张仪娜,郑玲利.癌症止痛药物利用与处方分析[J].中国煤炭工业医学杂志,2015,18(2):335-338.
[5]温永柯.我院癌痛患者三阶梯止痛药物使用调查分析[J].北方药学,2015,12(7):151-152.
[6]官毅红.晚期癌症患者麻醉药品用药情况分析[J].海峡药学,2015,27(11):226-227.
[7]程凯,蔡虹.2009年至2011年我院癌痛治疗药品利用分析[J].中国药业,2013,22(8):82-84.
[8]王晓梅,张倩,王松芝.2010~2011年我院病区麻醉药品应用分析[J].中国现代药物应用,2012,6(3):84-85.
[9]訾梅,李玉欢.我院癌痛示范病房2012年麻醉性镇痛药用药分析[J].首都医药,2013,20(10):55-57.
[10]李雪妍.我院门诊麻醉性镇痛药品使用情况分析[J].当代医学,2011,17(10):139-141.
[11]梁晓华.癌痛镇痛药物的规范应用[J].上海医药,2011,32(12):585-589.
[12]贺尔.癌性疼痛患者住院期间麻醉药品处方分析[J].中国药物滥用防治杂志,2012,18(2):99-101.
[13]樊艳丽,尹珊珊,朱珠.芬太尼透皮贴剂的安全性及其合理使用[J].药物不良反应杂志,2017,19(12):281.
[14]黄峰,艾素梅,王伟.2009-2011年住院患者麻醉性镇痛药应用分析与评价[J].实用医技杂志,2012,19(6):579-582.
[15]肖毅军,司红霞,王迎红,等.硫酸吗啡控释片剂量滴定控制癌性疼痛的临床研究[J].中国肿瘤临床,2000,38(2):42-45.
[16]李玉齐,秦鑫添,温宗秋.盐酸羟考酮控释片治疗中、重度癌痛的临床观察[J].中外医疗,2010,29(2):17-18,20.
[17]陈理明,李晓洁,谢晓原,等.镇痛泵持续静脉泵注吗啡控制难治性癌痛的临床观察[J].肿瘤防治研究,2016,39(8):1014-1016.
[18]石春生.2009-2011年我院麻醉药品应用分析[J].中国医院用药评价与分析,2017,12(7):594-596.